Skip to main content
. 2020 Sep 22;11(38):3531–3557. doi: 10.18632/oncotarget.27730

Figure 1. Alternative formats of engineered human antibodies.

Figure 1

(A) Domain organisation of an IgG molecule; (B) separation of antibody function by proteolytic cleavage; (C) schematic representation of multivalent recombinant antibody constructs.